Renal clearance of imipenem in children
- 32 Downloads
Imipenem renal clearance was studied in six children (three males, three females; 2.9–11.2 years of age) following a single intravenous dose (21.7±5.1 mg/kg) of imipenem/cilastatin (1∶1). In an approximately six-hour period following drug administration, 65.3±9.7% of the imipenem dose was excreted in the urine unchanged. The renal clearance (280.03±24.34 ml/min/1.73 m2) of imipenem was found to account for 69.2% of the corresponding plasma imipenem clearance (404.89±24.83 ml/min/1.73 m2). Contrary to existing adult data, the imipenem renal clearance in our subjects was 1.95-fold greater than the estimated creatinine clearance, suggesting significant tubular secretion of imipenem in children. Examination of urinary imipenem excretion rate versus plasma concentration relationships in three of the children revealed a potential renal tubular reabsorption component for imipenem in children. Comparison of renal imipenem clearance data in these children to similar data from adults suggests that quantitatively important developmental differences may exist for the renal handling of imipenem.
Unable to display preview. Download preview PDF.
- 1.Hanslo, D., King, A., Shannon, K., Warren, C., Phillips, I.: N-formimidoyl thienamycin (MK0787):in vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam, and other beta-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1981, 7: 607–617.PubMedGoogle Scholar
- 4.Norrby, S. R., Alestig, K., Björnegard, B., Burman, L. A., Ferber, F., Huber, J. L., Jones, K. H., Kahan, F. M., Kahan, J. S., Kropp, H., Meisinger, M. S., Sundelof, J. G.: Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors. Antimicrobial Agents and Chemotherapy 1983, 23: 300–307.PubMedGoogle Scholar
- 6.Reed, M. D., Stern, R. C., O'Brien, C. S., Myers, C. M., Blumer, J. L.: Efficacy and pharmacokinetics of imipenem/cilastatin in cystic fibrosis. Clinical Pharmacology and Therapeutics 1984, 35: 268.Google Scholar
- 8.Brown, R. D., Manno, J. F.: ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. Journal of Pharmaceutical Sciences 1978, 67: 1786–1791.Google Scholar
- 10.Gibaldi, M., Perrier, D.: One-compartment model. In: Gibaldi, M., Perrier, D. (ed.): Pharmacokinetics. 2nd Edition. Marcel Dekker, Inc., New York, 1982, p. 12.Google Scholar
- 11.Rowland, M., Tozer, T. N.: Clearance and renal excretion. In: Rowland, M., Tozer, T. N. (ed.): Clinical Pharmacokinetics: Concepts and Applications. Lea and Febiger, Philadelphia, 1980, p. 55–57.Google Scholar
- 12.Batson, H. D. (ed.: An Introduction to Statistics in the Medical Sciences. Burgess Publishing Co., Minneapolis, 1956, p. 55–61.Google Scholar
- 13.Dixon, W. J., Massey, F. J. (ed.: Introduction to Statistical Analysis. 3rd Edition. McGraw Hill Publishing Co., New York, 1956, p. 193–221.Google Scholar
- 14.Snedecor, G. W., Cochran, W. G. (ed.: Statistical Methods. 6th Edition. Iowa State University Press, Ames, 1967, p. 381–418.Google Scholar